Bumper Offer - Urjas oil Just @ Rs. 1
Metfine IPR is an allopathic medicine The correct dosage of Metfine IPR depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Metfine IPR is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Metfine IPR is used -
Severe
Moderate
Mild
Common
Is the use of Metfine IPR safe for pregnant women?
Metfine IPR rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Metfine IPR safe during breastfeeding?
Metfine IPR may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Metfine IPR, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Metfine IPR.
What is the effect of Metfine IPR on the Kidneys?
There are no side effects of Metfine IPR on the kidneys.
What is the effect of Metfine IPR on the Liver?
Using Metfine IPR does not have any harmful effects on the liver.
What is the effect of Metfine IPR on the Heart?
Using Metfine IPR does not have any harmful effects on the heart.
Metfine IPR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Metfine IPR unless your doctor advises you to do so -
Is this Metfine IPR habit forming or addictive?
No, you will not get addicted to Metfine IPR.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Metfine IPR since it does not cause drowsiness.
Is it safe?
Metfine IPR is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Metfine IPR cannot treat any kind of mental disorder.
Interaction between Food and Metfine IPR
Information is not available on the interaction of any foods with Metfine IPR, due to a lack of research on this.
Interaction between Alcohol and Metfine IPR
Taking alcohol with Metfine IPR can be dangerous.
Metfine IPR can be taken forever, diabetes is a progressive disease it's possible that more medication and/or insulin may eventually need to be added to the regime.
Metfine IPR should be taken with food to reduce stomach and bowel side effects, which may experience the first few weeks of treatment. Also, exercise regularly and test for sugar in your blood or urine as directed.
Metfine IPR increases the sensitivity of insulin, young women with PCOS often have elevated insulin levels and are more likely to develop diabetes. It is often prescribed for women with PCOS to help prevent diabetes. A lifestyle that includes healthy nutrition and daily exercise is the most important part of a PCOS treatment plan.
No, you should not take alcohol with Metfine IPR, because it can cause serious side effects which includes hypoglycemia (low blood sugar). The risk of hypoglycemia is higher when you're drinking and taking Metfine IPR than if you're just taking Metfine IPR. Some of the signs of hypoglycemia include dizziness, confusion, and drowsiness.
Metfine IPR is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
